Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study

Clinical trial NCT02067988 · COMPLETED

Trial details

NCT number: NCT02067988
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2014-02-01
Primary completion: 2019-09-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.